Your Custom Text Here
Venture capital is in the middle of a quiet power shift.
Over the past few years, some of the largest and most consequential deals in tech, healthcare and life sciences have not been led by traditional venture firms at all. Instead, family offices and sovereign wealth funds are backing bigger bets, longer timelines and platforms that stretch across borders, often outside the constraints of the traditional 10-year fund model. READ MORE
Generative AI was the dominant theme of venture capital in 2023 and will likely continue to be this year. However, investment in the sector is likely to become more specialized.
A record $29.1 billion was invested across 691 generative AI deals last year, according to PitchBook data. This represents a 268.4% increase in deal value over 2022’s total. READ MORE
As Big Tech investments proliferate across emerging startups—advancing everything from AI to crypto to biotech—markets brim with promise of human progress through innovation. But when titans extend tentacles into rising potential competitors, what whispers echo from conference rooms with two-way mirrors? Emerging trends around influence through minority board positions should spur regulators to reassess antitrust frameworks developed long before today's complex web of strategic investments between dominant platforms and startups. READ MORE
Investments in AI are growing at an accelerated pace, according to a new report from the Organization for Economic Cooperation and Development (OECD). The Paris, France-based group found that the U.S. and China lead the growing wave of funding, taking in a combined 81% of the total amount invested in AI startups last year, while the European Union and U.K. boosted their backing but lag substantially behind. READ MORE